Spire Wealth Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Spire Wealth Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-917	Closed	-$200K	–	3113
2021 Q1	$200K	Buy	+917	New	+$172K	0.01%	1064

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Spire Wealth Management's GWPH Position: Q2 2021 in Review

Spire Wealth Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 917 shares — an estimated $200K sold.

Spire Wealth Management first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $200K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Spire Wealth Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Spire Wealth Management sold 917 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $200K.
Spire Wealth Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
Spire Wealth Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $200K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Spire Wealth Management's 13F filing for Q2 2021, filed 26 Jul 2021.